腦膜炎疫苗市場按類型、品牌、血清型、銷售管道和地區分類

預計 2025 年全球腦膜炎疫苗市場規模為 39.7 億美元，到 2032 年將達到 63 億美元，2025 年至 2032 年的複合年成長率為 6.8%。

數字。 2025年腦膜炎疫苗市場佔有率（按地區）

腦膜炎是覆蓋大腦和脊髓的保護膜（即腦膜）的一種潛在致命的發炎。腦膜炎可由多種病原體引起，包括細菌、病毒、寄生蟲和真菌。腦膜炎最常見的原因是病毒和細菌感染。如果沒有及時使用適當的抗生素治療，由腦膜炎奈瑟菌、肺炎鏈球菌和 B 型流感嗜血桿菌引起的細菌感染會迅速變得嚴重，甚至致命。雖然及時使用抗生素治療可以治癒大多數細菌性腦膜炎病例，但 10-15％ 的病例仍會導致長期殘疾，如聽力喪失、神經發育遲緩、癲癇和截肢。建議接種疫苗，以預防腦膜炎奈瑟菌引起的侵襲性腦膜炎雙球菌疾病。腦膜炎球菌結合疫苗已被開發出來，可以提供直接保護和群體免疫，有效地限制疾病在社區內的傳播。

市場動態

全球腦膜炎疫苗市場的成長主要受到侵襲性腦膜炎雙球菌病菌感染負擔的增加以及世界各地大規模疫苗接種計劃的實施的推動。例如，根據世界衛生組織2021年發布的資料，腦膜炎每年導致約25萬至50萬例病例和3萬多例死亡，是公共衛生優先事項。預計在預測期內，引起疫情爆發的常見致病血清群的流行病學演變、各國監管機構的常規疫苗接種建議以及聯合疫苗的可用性將為市場提供強勁的成長機會。然而，製造和開發新疫苗的高成本、疫情期間疫苗缺貨以及中低收入國家缺乏認知等因素可能會阻礙市場發展。涵蓋新興血清型的可負擔多效價疫苗的開發以及開發中國家免疫計劃的擴大為參與者進入和進一步擴大市場提供了有利可圖的機會。

本研究的主要特點

本報告對全球腦膜炎疫苗市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。

它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

全球腦膜炎疫苗市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數列出的。

從本報告中獲得的見解將使負責人和企業經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球腦膜炎疫苗市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景
• 流行病學

4. 腦膜炎疫苗市場（按類型），2020-2032 年（十億美元）

• 二價
• 四價
• 其他

5. 腦膜炎疫苗市場（按品牌分類），2020-2032 年（十億美元）

• 門誇德菲
• 門貝奧
• 托爾門巴
• 貝克塞洛
• 其他

6. 腦膜炎疫苗市場，依年齡族群，2020-2032 年（十億美元）

• 嬰兒
• 成人

7. 腦膜炎疫苗市場，依血清型，2020-2032 年（十億美元）

• A血清群
• B血清群
• C血清群
• 血清型W-135
• 其他

8. 腦膜炎疫苗市場，依銷售管道，2020-2032 年（十億美元）

• 私人的
• 公共

9. 腦膜炎疫苗市場（按地區分類），2020-2032 年（十億美元）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第10章 競爭格局

• Pfizer Inc.
• Sanofi
• GSK plc.
• Serum Institute of India Ltd.
• Merck & co., Inc.
• Walvax Biotechnology Co., Ltd.
• Icepta Pharmaceuticals Ltd.
• Hualan Biological Engineering Inc.

第 11 章分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第12章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Global Meningitis Vaccines Market is estimated to be valued at USD 3.97 Bn in 2025 and is expected to reach USD 6.30 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Figure. Meningitis Vaccines Market Share (%), By Region 2025

Meningitis is a potentially fatal inflammation of the protective membranes covering the brain and spinal cord known as meninges. It can be caused by various pathogens such as bacteria, viruses, parasites, and fungi. The most common causes of meningitis are viral and bacterial infections. Bacterial infections including those caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b can rapidly lead to serious illness and even death if not treated promptly with appropriate antibiotics. While timely treatment with antibiotics can cure most cases of bacterial meningitis, the infection may still lead to long-term disability in 10-15% of cases such as hearing loss, neurodevelopmental delay, and epilepsy or limb amputations. To prevent the occurrence of invasive meningococcal disease caused by N. meningitidis, vaccination is recommended. Meningococcal conjugate vaccines have been created to provide both direct protection and herd immunity, effectively controlling the spread of the disease within communities.

Market Dynamics

Global meningitis vaccines market growth is primarily driven by increasing burden of invasive meningococcal disease and implementation of large-scale immunization programs worldwide. For instance, as per the data published by the World Health Organization (WHO) in 2021, meningitis causes approximately 250,000-500,000 cases annually resulting in over 30,000 deaths, making it a public health priority. Evolving epidemiology of common pathogenic serogroups causing outbreaks, recommendations for routine immunization by national regulatory bodies and availability of vaccine combinations are expected to create robust growth opportunities in the market during the forecast period. However, factors such as high costs associated with the manufacturing and development of novel vaccines, vaccine stockouts during outbreaks, and lack of awareness in low and middle-income countries can hamper the market growth. Development of affordable multivalent vaccines covering emerging serotypes and expansion of immunization programs in developing nations present lucrative opportunities for player engagement and further market expansion.

Key Features of the Study

This report provides in-depth analysis of the global meningitis vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Sanofi, GSK plc., Serum Institute of India Ltd., Merck & co., Inc., Walvax Biotechnology Co., Ltd., Icepta Pharmaceuticals Ltd., and Hualan Biological Engineering Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

• Type Insights
  • Bivalent
  • Quadrivalent
  • Others
• Brand Insights
  • MenQuadfi
  • Menveo
  • Trumenba
  • Bexsero
  • Others
• Age Group Insights
  • Infants
  • Adults
• Serotype Insights
  • Serotype A
  • Serotype B
  • Serotype C
  • Serotype W-135
  • Others
• Sales Channel Insights
  • Private
  • Public
• Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Pfizer Inc.
  • Sanofi
  • GSK plc.
  • Serum Institute of India Ltd.
  • Merck & co., Inc.
  • Walvax Biotechnology Co., Ltd.
  • Icepta Pharmaceuticals Ltd.
  • Hualan Biological Engineering Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Meningitis Vaccines Market, By Type
  • Meningitis Vaccines Market, By Brand
  • Meningitis Vaccines Market, By Age Group
  • Meningitis Vaccines Market, By Serotype
  • Meningitis Vaccines Market, By Sales Channel
  • Meningitis Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Epidemiology

4. Meningitis Vaccines Market, By Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Bivalent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Quadrivalent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Meningitis Vaccines Market, By Brand, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• MenQuadfi
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Menveo
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Trumenba
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bexsero
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Meningitis Vaccines Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Infants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Meningitis Vaccines Market, By Serotype, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Serotype A
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Serotype B
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Serotype C
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Serotype W-135
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Meningitis Vaccines Market, By Sales Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Private
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Public
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Meningitis Vaccines Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Brand, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Serotype, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, Country/Region, 2020 - 2032, (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GSK plc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Serum Institute of India Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Walvax Biotechnology Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Icepta Pharmaceuticals Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hualan Biological Engineering Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us